Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03004326 · ClinicalTrials.gov registry record
Clinical Transcriptomics in Systemic Vasculitis (CUTIS)
A clinical trial of Vasculitis and IgA Vasculitis, sponsored by Peter Merkel.
- Recruiting
- Registry status
- 50
- Enrollment target
- 10
- Study locations
NCT03004326: Recruiting study of Vasculitis and IgA Vasculitis, sponsored by Peter Merkel.
NCT03004326 is a study of Vasculitis and IgA Vasculitis that is actively recruiting participants, run by Peter Merkel. The registered enrollment target is 50 participants, below the 27,314-participant average among 11 other Vasculitis trials with a reported enrollment target (100% lower). The trial reports 10 study locations across 9 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03004326, a study of Vasculitis and IgA Vasculitis, is actively recruiting participants, sponsored by Peter Merkel.
- RECRUITING
- Registry status
- 50 participants
- Enrollment target
- 10
- Study locations
Study Summary
Multi-center observational study to evaluate the histopathology and transcriptome of cutaneous lesions in patients with several different types of vasculitis.
Primary Outcome
Describe cutaneous vasculitis across several different forms of systemic vasculitis using histopathology.
Conditions Studied
Study Locations (10)
Ontario
- St. Joseph's Healthcare - Hamilton
- University of Toronto Mount Sinai Hospital - Toronto
California
- University of California, Los Angeles - Los Angeles
Massachusetts
- Boston University School of Medicine - Boston
Minnesota
- Mayo Clinic - Rochester
Ohio
- Cleveland Clinic - Cleveland
Oregon
- Oregon Health & Science University - Portland
Pennsylvania
- University of Pennsylvania - Philadelphia
Utah
- University of Utah - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2017-01 |
| Est. Completion | 2028-12 |
What NCT03004326 shows while recruiting
NCT03004326 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 27,314-participant average among 11 other Vasculitis trials with a reported enrollment target (100% lower).
The record links to 10 conditions, with Vasculitis appearing as the primary indexed condition, and to 0 interventions.
NCT03004326 lists 10 locations in 9 states (Ontario, California, Massachusetts).
Frequently Asked Questions
What is clinical trial NCT03004326 about?
NCT03004326 is a clinical study titled "Clinical Transcriptomics in Systemic Vasculitis (CUTIS)". Multi-center observational study to evaluate the histopathology and transcriptome of cutaneous lesions in patients with several different types of vasculitis.
What is the current status of trial NCT03004326?
This trial is currently recruiting. The enrollment target is 50 participants. The study started on 2017-01. Estimated completion is 2028-12.
What conditions does trial NCT03004326 study?
This clinical trial studies the following conditions: Vasculitis, IgA Vasculitis, Eosinophilic Granulomatosis With Polyangiitis (EGPA), Granulomatosis With Polyangiitis (GPA), Microscopic Polyangiitis (MPA).
Who is sponsoring clinical trial NCT03004326?
This trial is sponsored by Peter Merkel, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03004326 being conducted?
This trial has 10 study locations across California, Massachusetts, Minnesota, Ohio, Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Vasculitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03004326's enrollment target sits among peer trials
50 6th of 11 higher than 6 of 11 other Vasculitis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Vasculitis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Longitudinal Study for Relapsing Polychondritis
RECRUITING
-
Infliximab Therapy for Dolichoectactic Vertebrobasilar Aneurysms
RECRUITING · Phase 1
-
A Real-World Registry of Chronic Wounds and Ulcers
RECRUITING
-
Vasculitis Pregnancy Registry
RECRUITING
-
Longitudinal Study for Central Nervous System Vasculitis
RECRUITING
-
Study to Evaluate Avacopan in Combination With a Rituximab or Cyclophosphamide-containing Regimen, in Children From 6 Years to < 18 Years of Age With AAV.
RECRUITING · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia